Phase
Condition
Glaucoma
Open Angle Glaucoma
Vision Loss
Treatment
Competitor Device
ELIOS
iStent inject W
Clinical Study ID
Ages > 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female subjects.
40 years old or older.
Diagnosis of mild to moderate primary open-angle glaucoma, pseudoexfoliationglaucoma or pigmentary glaucoma:
Visually significant cataract eligible for phacoemulsification.
Exclusion
Exclusion Criteria:
All forms of angle closure glaucoma
Secondary glaucoma, including traumatic, neovascular, uveitic, lens-induced,steroid-induced, angle-recession, glaucoma associated with vascular disorders, andglaucoma associated with increased episcleral venous pressure
Congenital or developmental glaucoma
Prior incisional glaucoma surgery, intraocular surgery or ocular laser treatment ofany type with the exception of selective laser trabeculoplasty (SLT) occurring aminimum of 6 months prior to the Screening visit
Study Design
Connect with a study center
ELIOS Clinical Site
Leuven,
BelgiumActive - Recruiting
ELIOS Clinical Site
Bordeaux,
FranceActive - Recruiting
ELIOS clinical site
Paris,
FranceActive - Recruiting
ELIOS Clinical Site
Bochum,
GermanyActive - Recruiting
ELIOS clinical site
Heidelberg,
GermanyActive - Recruiting
ELIOS Clinical Site
Maastricht,
NetherlandsActive - Recruiting
ELIOS clinical site
Barcelona,
SpainActive - Recruiting
ELIOS Clincal Site
Madrid,
SpainActive - Recruiting
ELIOS Clinical site
Madrid,
SpainActive - Recruiting
ELIOS Clinical Site
Edinburgh,
United KingdomActive - Recruiting
ELIOS Clinical Site
Guildford,
United KingdomActive - Recruiting
ELIOS Clinical Site
London,
United KingdomActive - Recruiting
ELIOS clinical site
London,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.